Verbatim response from Perplexity
The primary difference between compounded semaglutide and brand-name semaglutide (such as Ozempic or Wegovy) is that brand-name versions are FDA-approved and rigorously tested, while compounded versions are not FDA-approved and lack standardized manufacturing oversight [1][2].
Key Differences
| Feature | Brand-Name Semaglutide | Compounded Semaglutide |
|---|---|---|
| Regulatory Approval | FDA-approved after large-scale clinical trials [1][3] | Not FDA-approved; no rigorous premarket review [2][6] |
| Manufacturing | Made by Novo Nordisk under strict national quality standards [1][5] | Custom-made by state-licensed compounding pharmacies in small batches [1][2] |
| Active Ingredient | Uses semaglutide base (the approved form) [5][7] | May use semaglutide base or unapproved salts (e.g., sodium, acetate) [5][8] |
| Consistency | Each batch meets specified purity and dosing standards [1][2] | Quality, potency, and sterility can vary between batches [2][3] |
| Delivery Format | Pre-filled injectable pens (4–8 doses each) [5] | Small glass vials; requires drawing dose with syringe [5] |
| Cost | ~$1,000 retail price [5] | Significantly lower, often 50–70% cheaper [3][4] |
Is Compounded Semaglutide Safe?
Compounded semaglutide carries real safety risks and is not considered as safe or reliable as the brand-name product [2][3]. Key concerns include:
- Dosing errors: The FDA has received reports of incorrect dosing in compounded products [5][7].
- Contamination: Lack of standardized sterility testing increases risk of impurities [2][7].
- Unapproved ingredients: Some compounded versions contain semaglutide salts (sodium, acetate) with no evidence of safety or efficacy [5][8].
- Adverse events: The FDA estimates 10 deaths and 100 hospitalizations may be linked to compounded GLP-1s [9].
- Medical guidance: Leading organizations like the American Diabetes Association and Obesity Medicine Association recommend against using non-FDA-approved compounded GLP-1s [3].
While some sources state compounded semaglutide can be safe if prescribed and monitored by a qualified provider and sourced from a trusted pharmacy [1], this is not the mainstream medical consensus. The FDA explicitly advises preferring FDA-approved brand-name medications when available [7].
Bottom Line
For safety, consistency, and proven efficacy, brand-name semaglutide (Ozempic, Wegovy) is the recommended choice [1][3][7]. Compounded semaglutide should only be considered when brand-name options are unavailable due to shortages and only under strict medical supervision, with full awareness of the risks [1][9].